ImmunityBio (IBRX) Earnings Date, Estimates & Call Transcripts → This Apple-like Innovator is Revolutionizing Healthcare (From Wall Street Star) (Ad) Free IBRX Stock Alerts $6.66 -0.38 (-5.40%) (As of 01:09 PM ET) Add Compare Share Share EarningsStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial MediaStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial Media Earnings SummaryUpcoming Earnings DateAug. 13EstimatedActual EPS (Mar. 19) -$0.19 Missed By -$0.01 Consensus EPS (Mar. 19) -$0.18 Get ImmunityBio Earnings AlertsEnter your email address below to receive the latest news and earnings results for IBRX and its competitors with MarketBeat's FREE daily newsletter. Skip Charts & View Estimated and Actual Earnings DataEarnings Per ShareRevenueIBRX Earnings Estimates and Actuals by QuarterEarnings Estimates and Acutals by Quarter Chart DescriptionThe chart below shows up to four years of a company's earnings history. The dark blue line represents the company's actual earnings per share. The light blue area represents the range of Wall Street analysts' earnings estimates for each quarter.IBRX Estimated and Actual Revenue by Quarter Estimated Revenue and Actual Revenue by Quarter Chart DescriptionThe chart below shows up to four years of a company's revenue history. The dark blue line represents the company's actual revenue. The light blue line represents the company's estimated revenue based on the consensus of Wall Street analysts for each quarter. Ad DTIThree basic steps to building the Ultimate Dividend Portfolio.There are three basic steps to building the Ultimate Dividend Portfolio. Step #1 is to Get The High Yields! So an index fund like the SPY, paying only 1.5% a year, isn’t going to cut it. But a company like Altria Group (MO) will.Click here to get them (for Free). ImmunityBio Analyst EPS EstimatesCurrent Year EPS Consensus Estimate:($0.75) EPSNext Year EPS Consensus Estimate: ($0.52) EPSIBRX Earnings Date and InformationImmunityBio last posted its earnings data on March 19th, 2024. The reported ($0.19) earnings per share (EPS) for the quarter, missing analysts' consensus estimates of ($0.18) by $0.01. The firm earned $0.14 million during the quarter, compared to analysts' expectations of $0.03 million. ImmunityBio has generated ($1.09) earnings per share over the last year (($1.09) diluted earnings per share). Earnings for ImmunityBio are expected to grow in the coming year, from ($0.75) to ($0.52) per share. ImmunityBio has not formally confirmed its next earnings publication date, but the company's estimated earnings date is Tuesday, August 13th, 2024 based off prior year's report dates.Read More ImmunityBio Earnings History by Quarter Custom Range 3 Months 6 Months Year-to-Date 1 Year 2 Years 3 Years 5 Years 10 Years Time Frame * Start Date * End Date Export to Excel DateQuarterConsensus EstimateReported EPSBeat/MissGAAP EPSRevenue EstimateActual RevenueCall Transcript 8/13/2024(Estimated)------- 3/19/2024Q4 2023($0.18)($0.19)($0.01)-$0.03 million$0.14 million11/8/2023Q3 2023($0.27)($0.19)+$0.08($0.19)-$0.08 million8/8/2023Q2 2023($0.26)($0.28)($0.02)($0.24)$0.03 million$0.04 million5/11/2023Q1 2023($0.27)($0.27)-($0.27)-$0.36 million11/8/2022Q3 2022($0.23)($0.28)($0.05)($0.28)$0.03 million$0.12 million5/10/2022Q1 2022($0.22)($0.26)($0.04)($0.26)$0.03 million$0.01 million Get the Latest News and Ratings for IBRX and Related StocksEnter your email address below to receive the latest news and analysts' ratings for ImmunityBio and its competitors with MarketBeat's FREE daily newsletter. 8/12/2021Q2 2021($0.12)($0.23)($0.11)($0.23)$0.03 million$0.34 million8/7/2020Q2 2020($0.19)($0.20)($0.01)($0.20)--5/11/2020Q1 2020($0.17)($0.19)($0.02)($0.19)-$0.02 million3/25/2020Q4 2019($0.20)($0.16)+$0.04($0.16)-$0.01 million11/5/2019Q3 2019-($0.16)($0.16)($0.16)-$0.01 million8/6/2019Q2 2019($0.25)($0.17)+$0.08($0.17)-$0.02 million ImmunityBio Earnings - Frequently Asked Questions When is ImmunityBio's earnings date? ImmunityBio has not confirmed its next earnings publication date, but the company's estimated earnings date is Tuesday, August 13th, 2024 based off last year's report dates. Learn more on IBRX's earnings history. Did ImmunityBio beat their earnings estimates last quarter? In the previous quarter, ImmunityBio (NASDAQ:IBRX) missed the analysts' consensus estimate of ($0.18) by $0.01 with a reported earnings per share (EPS) of ($0.19). Learn more on analysts' earnings estimate vs. IBRX's actual earnings. How much revenue does ImmunityBio generate each year? ImmunityBio (NASDAQ:IBRX) has a recorded annual revenue of $620,000.00. How much profit does ImmunityBio generate each year? ImmunityBio (NASDAQ:IBRX) has a recorded net income of -$583.20 million. IBRX has generated -$1.09 earnings per share over the last four quarters. What is ImmunityBio's EPS forecast for next year? ImmunityBio's earnings are expected to grow from ($0.75) per share to ($0.52) per share in the next year. More Earnings Resources from MarketBeat Related Companies: Halozyme Therapeutics Earnings Date Revolution Medicines Earnings Date Exelixis Earnings Date CRISPR Therapeutics Earnings Date Krystal Biotech Earnings Date Immunovant Earnings Date Vaxcyte Earnings Date SpringWorks Therapeutics Earnings Date Iovance Biotherapeutics Earnings Date Denali Therapeutics Earnings Date Earnings Tools: Today's Earnings Tomorrow's Earnings Next Week's Earnings Upcoming Earnings Calls Earnings Newsletter Earnings Call Transcripts Earnings Beats & Misses Corporate Guidance Earnings Screener Earnings By Country: U.S. Earnings Reports Canadian Earnings Reports U.K. Earnings Reports Australia Earnings Reports Latest Articles: Baidu Stock Earnings Prove Ray Dalio Right about China?JD’s Earnings Could Mean Chinese Stocks Making a ComebackHome Depot: Earnings Mixed, Wait to Buy the DipTraders Sell but Investors Still Win After Palantir's EarningsTech Earnings Insights: Where Opportunity Meets UncertaintyApple’s Earnings Show Investors Its Strength and Its WeaknessCarvana’s Q1 Earnings: A Profitability U-Turn This page (NASDAQ:IBRX) was last updated on 5/21/2024 by MarketBeat.com Staff From Our PartnersNext President (Not Trump. Not Biden.)The Freeport SocietyConflict In Israel Sends Gold Soaring ???? Here’s How To Get Your ShareColonial Metals[FREE Ticket] 27 Crypto Experts Reveal Their #1 Picks Crypto 101 MediaClaim Your Complimentary Bitcoin RewardCrypto Swap ProfitsProtect Your Bank Account Before It’s Too LateWeiss Ratings4 Cryptos BETTER than BitcoinTrue Market InsidersBuy this small stock before coming AI Tidal WaveChaikin AnalyticsThis Apple-like Innovator is Revolutionizing HealthcareWall Street Star Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding ImmunityBio, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.